X |
Filing Date |
Trade Date |
Ticker |
Insider Name | Title |
Trade Type |
Price |
Qty |
Owned |
ΔOwn |
Value |
1d |
1w |
1m |
6m |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2026-01-05 | EYPT | Ribeiro Ramiro | Chief Medical Officer | S - Sale+OE | $17.10 | -42,544 | 0 | -100% | -$727,319 | |||||
2025-12-04 | EYPT | Cormorant Asset Management, LP | Former 10% Owner | S - Sale | $15.70 | -60,000 | 8,265,000 | -1% | -$942,240 | ||||||
2025-12-04 | EYPT | Lurker Nancy | Dir | S - Sale | $15.11 | -9,300 | 333,436 | -3% | -$140,477 | ||||||
| M | 2025-11-26 | EYPT | Lurker Nancy | Dir | S - Sale | $14.95 | -700 | 342,736 | 0% | -$10,465 | |||||
2025-11-11 | EYPT | Ribeiro Ramiro | Chief Medical Officer | S - Sale | $11.61 | -2,722 | 0 | -100% | -$31,602 | ||||||
| M | 2025-05-16 | EYPT | Zaderej Karen L. | Dir | P - Purchase | $5.90 | +10,000 | 36,500 | +38% | +$59,000 | |||||
| M | 2025-05-14 | EYPT | Zaderej Karen L. | Dir | P - Purchase | $5.45 | +10,000 | 26,500 | +61% | +$54,450 | |||||
2024-08-20 | EYPT | Dicicco Wendy F | Dir | P - Purchase | $7.79 | +2,567 | 9,967 | +35% | +$19,997 | ||||||
2024-08-21 | EYPT | Ando Goran | Dir | P - Purchase | $7.95 | +5,000 | 13,150 | +61% | +$39,750 | ||||||
2024-08-19 | EYPT | Zaderej Karen L. | Dir | P - Purchase | $7.98 | +12,500 | 16,500 | +313% | +$99,750 | ||||||
2024-08-16 | EYPT | Lurker Nancy | Dir | P - Purchase | $7.88 | +3,173 | 224,524 | +1% | +$25,003 | ||||||
| D | 2024-07-12 | EYPT | Guyer David R | Dir | S - Sale+OE | $10.06 | -11,625 | 1,850 | -86% | -$116,995 | |||||
| D | 2024-06-03 | EYPT | Guyer David R | Dir | S - Sale+OE | $10.30 | -11,625 | 3,700 | -76% | -$119,705 | |||||
| D | 2024-05-14 | EYPT | Guyer David R | Dir | S - Sale+OE | $12.65 | -11,625 | 5,550 | -68% | -$147,045 | |||||
2024-05-06 | EYPT | Cormorant Asset Management, LP | 10% | P - Purchase | $11.86 | +850,000 | 8,325,000 | +11% | +$10,081,721 | ||||||
2024-04-18 | EYPT | Cormorant Asset Management, LP | 10% | P - Purchase | $18.03 | +581,765 | 7,475,000 | +8% | +$10,489,446 | ||||||
| D | 2024-02-02 | EYPT | Jones David Scott | SVP, Chief Commercial Officer | S - Sale+OE | $28.49 | -209 | 37,962 | -1% | -$5,954 |
| A | Amended filing |
| D | Derivative transaction in filing (usually option exercise) |
| E | Error detected in filing |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |